It is a business services private limited company based in Delhi, Delhi, India, established in 2025.
2025 | Delhi, Delhi, India | ActiveSyngonium Pharmaceuticals Private Limited, a active private limited company, was established on 14 January 2025 in Delhi, Delhi, India. it holds CIN: U46497DL2025PTC441096. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.00 M.
Its leadership includes Kumari Priyanka (Director), Bimlesh Kumar (Director). It is based at H.No 164,1St Floor Type-A, Pkt 1, Sec 24 Rohini, Delhi, Delhi, 110085.
U46497DL2025PTC441096
441096
14 January 2025
₹1.50 M
₹1.00 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Syngonium Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kumari Priyanka | Director | 14 Jan 2025 | Current |
| Bimlesh Kumar | Director | 14 Jan 2025 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Syngonium Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Syngonium Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Syngonium Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Syngonium Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Kumari Priyanka was appointed as a Director was appointed as a Director on 14 Jan 2025 & has been associated with this company since 10 months 11 days . was documented.
Progress on Bimlesh Kumar was appointed as a Director was appointed as a Director on 14 Jan 2025 & has been associated with this company since 10 months 11 days . was documented.
Syngonium Pharmaceuticals Private Limited was registered on 14 Jan 2025 with Roc Delhi & aged 10 months 11 days as per MCA records. was recorded as a recent event.
The CIN of Syngonium Pharmaceuticals Private Limited is U46497DL2025PTC441096.
Syngonium Pharmaceuticals Private Limited is headquartered at H.No 164,1St Floor Type-A, Pkt 1, Sec 24 Rohini, Delhi, Delhi, 110085.
Syngonium Pharmaceuticals Private Limited was incorporated on 14 January 2025.
The current directors of Syngonium Pharmaceuticals Private Limited are
Syngonium Pharmaceuticals Private Limited is unlisted.
The authorized capital of Syngonium Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX